Table 3 Logistic regression in eyes with baseline visual impairment.
Location | Variable | B | S.E. | p | Exp (B) |
|---|---|---|---|---|---|
Central edema | Macular volume enlargement | −0.842 | 0.38 | 0.027* | 0.43 |
Arterial hypertension | −0.569 | 0.36 | 0.109 | 0.57 | |
Proliferative retinopathy | 0.355 | 0.39 | 0.363 | 1.43 | |
Center point thickening | −0.361 | 0.59 | 0.538 | 0.69 | |
Female gender | −0.161 | 0.35 | 0.647 | 0.85 | |
Central edema | −0.375 | 1.42 | 0.792 | 0.69 | |
Center field thickening | 0.124 | 1.31 | 0.925 | 1.13 | |
Constant | 1.255 | 0.38 | 0.001* | 3.51 | |
Central and paracentral edema | Macular volume enlargement | −0.704 | 0.38 | 0.068 | 0.49 |
Arterial hypertension | −0.610 | 0.36 | 0.089 | 0.54 | |
Central and paracentral edema | 0.874 | 0.54 | 0.106 | 2.39 | |
Proliferative retinopathy | 0.368 | 0.39 | 0.344 | 1.44 | |
Center point thickening | −0.320 | 0.53 | 0.548 | 0.73 | |
Center field thickening | 0.296 | 0.61 | 0.631 | 1.34 | |
Female gender | −0.114 | 0.35 | 0.748 | 0.89 | |
Constant | 0.558 | 0.55 | 0.311 | 1.75 |